APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pronase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pronase Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchPronase Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pronase Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Pronase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pronase Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pronase Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pronase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pronase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pronase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pronase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pronase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pronase market include CHIA TAI TIANQING PHARMACEUTICAL GROUP, Yihe Biotech, Beijing Tide Pharmaceutical, Shanghai Yuanye Bio-Technology, Shanghai Yiyan Bio-Technology, QiMing Biotech, Shanghai Kanglang Biotechnology, Shanghai Gelatins and Shanghai Acmec Biochemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pronase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pronase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pronase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pronase market size, projected growth trends, production technologies, key applications, and end-use industries.

Pronase Segment by Company

CHIA TAI TIANQING PHARMACEUTICAL GROUP

Yihe Biotech

Beijing Tide Pharmaceutical

Shanghai Yuanye Bio-Technology

Shanghai Yiyan Bio-Technology

QiMing Biotech

Shanghai Kanglang Biotechnology

Shanghai Gelatins

Shanghai Acmec Biochemical

Roche

Anpel

VWR

Merck Millipore

Pronase Segment by Type

Pharmaceutical Grade

Research Reagent Grade

Pronase Segment by Application

Medical

Research

Pronase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pronase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pronase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pronase significant trends, drivers, influence factors in global and regions.

6. To analyze Pronase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pronase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pronase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pronase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pronase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pronase industry.

Chapter 3: Detailed analysis of Pronase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pronase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pronase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pronase Industry Trends Table 2. Pronase Industry Drivers Table 3. Pronase Industry Opportunities and Challenges Table 4. Pronase Industry Restraints Table 5. Global Pronase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pronase Revenue Share by Company (2021-2026) Table 7. Global Pronase Sales Volume by Company (kg) & (2021-2026) Table 8. Global Pronase Sales Volume Share by Company (2021-2026) Table 9. Global Pronase Average Price (US$/g) of Company (2021-2026) Table 10. Global Pronase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pronase Key Company Manufacturing Base & Headquarters Table 12. Global Pronase Company, Product Type & Application Table 13. Global Pronase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pronase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pharmaceutical Grade Table 18. Significant Companies of Research Reagent Grade Table 19. Global Pronase Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Pronase Sales Volume by Type (2021-2026) & (kg) Table 21. Global Pronase Sales Volume by Type (2027-2032) & (kg) Table 22. Global Pronase Sales Volume Share by Type (2021-2026) Table 23. Global Pronase Sales Volume Share by Type (2027-2032) Table 24. Global Pronase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pronase Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pronase Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pronase Sales Value Share by Type (2021-2026) Table 28. Global Pronase Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Table 30. Significant Companies of Research Table 31. Global Pronase Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Pronase Sales Volume by Application (2021-2026) & (kg) Table 33. Global Pronase Sales Volume by Application (2027-2032) & (kg) Table 34. Global Pronase Sales Volume Share by Application (2021-2026) Table 35. Global Pronase Sales Volume Share by Application (2027-2032) Table 36. Global Pronase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pronase Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Pronase Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Pronase Sales Value Share by Application (2021-2026) Table 40. Global Pronase Sales Value Share by Application (2027-2032) Table 41. Global Pronase Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Pronase Sales by Region (2021-2026) & (kg) Table 43. Global Pronase Sales Market Share by Region (2021-2026) Table 44. Global Pronase Sales by Region (2027-2032) & (kg) Table 45. Global Pronase Sales Market Share by Region (2027-2032) Table 46. Global Pronase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pronase Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Pronase Sales Value Share by Region (2021-2026) Table 49. Global Pronase Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Pronase Sales Value Share by Region (2027-2032) Table 51. Global Pronase Market Average Price (US$/g) by Region (2021-2026) Table 52. Global Pronase Market Average Price (US$/g) by Region (2027-2032) Table 53. Global Pronase Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Global Pronase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Pronase Sales by Country (2021-2026) & (kg) Table 56. Global Pronase Sales Market Share by Country (2021-2026) Table 57. Global Pronase Sales by Country (2027-2032) & (kg) Table 58. Global Pronase Sales Market Share by Country (2027-2032) Table 59. Global Pronase Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Pronase Sales Value Market Share by Country (2021-2026) Table 61. Global Pronase Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Pronase Sales Value Market Share by Country (2027-2032) Table 63. CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information Table 64. CHIA TAI TIANQING PHARMACEUTICAL GROUP Business Overview Table 65. CHIA TAI TIANQING PHARMACEUTICAL GROUP Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. CHIA TAI TIANQING PHARMACEUTICAL GROUP Pronase Product Portfolio Table 67. CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Development Table 68. Yihe Biotech Company Information Table 69. Yihe Biotech Business Overview Table 70. Yihe Biotech Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Yihe Biotech Pronase Product Portfolio Table 72. Yihe Biotech Recent Development Table 73. Beijing Tide Pharmaceutical Company Information Table 74. Beijing Tide Pharmaceutical Business Overview Table 75. Beijing Tide Pharmaceutical Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Beijing Tide Pharmaceutical Pronase Product Portfolio Table 77. Beijing Tide Pharmaceutical Recent Development Table 78. Shanghai Yuanye Bio-Technology Company Information Table 79. Shanghai Yuanye Bio-Technology Business Overview Table 80. Shanghai Yuanye Bio-Technology Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Shanghai Yuanye Bio-Technology Pronase Product Portfolio Table 82. Shanghai Yuanye Bio-Technology Recent Development Table 83. Shanghai Yiyan Bio-Technology Company Information Table 84. Shanghai Yiyan Bio-Technology Business Overview Table 85. Shanghai Yiyan Bio-Technology Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Shanghai Yiyan Bio-Technology Pronase Product Portfolio Table 87. Shanghai Yiyan Bio-Technology Recent Development Table 88. QiMing Biotech Company Information Table 89. QiMing Biotech Business Overview Table 90. QiMing Biotech Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. QiMing Biotech Pronase Product Portfolio Table 92. QiMing Biotech Recent Development Table 93. Shanghai Kanglang Biotechnology Company Information Table 94. Shanghai Kanglang Biotechnology Business Overview Table 95. Shanghai Kanglang Biotechnology Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Shanghai Kanglang Biotechnology Pronase Product Portfolio Table 97. Shanghai Kanglang Biotechnology Recent Development Table 98. Shanghai Gelatins Company Information Table 99. Shanghai Gelatins Business Overview Table 100. Shanghai Gelatins Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Shanghai Gelatins Pronase Product Portfolio Table 102. Shanghai Gelatins Recent Development Table 103. Shanghai Acmec Biochemical Company Information Table 104. Shanghai Acmec Biochemical Business Overview Table 105. Shanghai Acmec Biochemical Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. Shanghai Acmec Biochemical Pronase Product Portfolio Table 107. Shanghai Acmec Biochemical Recent Development Table 108. Roche Company Information Table 109. Roche Business Overview Table 110. Roche Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Roche Pronase Product Portfolio Table 112. Roche Recent Development Table 113. Anpel Company Information Table 114. Anpel Business Overview Table 115. Anpel Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. Anpel Pronase Product Portfolio Table 117. Anpel Recent Development Table 118. VWR Company Information Table 119. VWR Business Overview Table 120. VWR Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. VWR Pronase Product Portfolio Table 122. VWR Recent Development Table 123. Merck Millipore Company Information Table 124. Merck Millipore Business Overview Table 125. Merck Millipore Pronase Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 126. Merck Millipore Pronase Product Portfolio Table 127. Merck Millipore Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Pronase Distributors List Table 131. Pronase Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Pronase Product Image Figure 2. Global Pronase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pronase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pronase Sales (2021-2032) & (kg) Figure 5. Global Pronase Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Pronase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pharmaceutical Grade Image Figure 10. Research Reagent Grade Image Figure 11. Global Pronase Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Pronase Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pronase Sales Volume Share by Type (2021-2032) Figure 14. Global Pronase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pronase Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pronase Sales Value Share by Type (2021-2032) Figure 17. Medical Image Figure 18. Research Image Figure 19. Global Pronase Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Pronase Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Pronase Sales Volume Share by Application (2021-2032) Figure 22. Global Pronase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pronase Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Pronase Sales Value Share by Application (2021-2032) Figure 25. Global Pronase Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 26. Global Pronase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Pronase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Pronase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Pronase Sales Value (2021-2032) & (US$ Million) Figure 30. North America Pronase Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Pronase Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Pronase Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Pronase Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Pronase Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Pronase Sales Value (2021-2032) & (US$ Million) Figure 36. South America Pronase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Pronase Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Pronase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Pronase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Pronase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Pronase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Pronase Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Pronase Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade
  • Research Reagent Grade
Applications
  • Medical
  • Research
Companies covered
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP
  • Yihe Biotech
  • Beijing Tide Pharmaceutical
  • Shanghai Yuanye Bio-Technology
  • Shanghai Yiyan Bio-Technology
  • QiMing Biotech
  • Shanghai Kanglang Biotechnology
  • Shanghai Gelatins
  • Shanghai Acmec Biochemical
  • Roche
  • Anpel
  • VWR
  • Merck Millipore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pronase Sales Value (2021-2032)
  4. 1.2.2 Global Pronase Sales Volume (2021-2032)
  5. 1.2.3 Global Pronase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pronase Market Dynamics
  1. 2.1 Pronase Industry Trends
  2. 2.2 Pronase Industry Drivers
  3. 2.3 Pronase Industry Opportunities and Challenges
  4. 2.4 Pronase Industry Restraints
3 Pronase Market by Company
  1. 3.1 Global Pronase Company Revenue Ranking in 2025
  2. 3.2 Global Pronase Revenue by Company (2021-2026)
  3. 3.3 Global Pronase Sales Volume by Company (2021-2026)
  4. 3.4 Global Pronase Average Price by Company (2021-2026)
  5. 3.5 Global Pronase Company Ranking (2024-2026)
  6. 3.6 Global Pronase Company Manufacturing Base and Headquarters
  7. 3.7 Global Pronase Company Product Type and Application
  8. 3.8 Global Pronase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pronase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pronase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pronase Market by Type
  1. 4.1 Pronase Type Introduction
  2. 4.1.1 Pharmaceutical Grade
  3. 4.1.2 Research Reagent Grade
  4. 4.2 Global Pronase Sales Volume by Type
  5. 4.2.1 Global Pronase Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pronase Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pronase Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pronase Sales Value by Type
  9. 4.3.1 Global Pronase Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pronase Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pronase Sales Value Share by Type (2021-2032)
5 Pronase Market by Application
  1. 5.1 Pronase Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Research
  4. 5.2 Global Pronase Sales Volume by Application
  5. 5.2.1 Global Pronase Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pronase Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pronase Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pronase Sales Value by Application
  9. 5.3.1 Global Pronase Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pronase Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pronase Sales Value Share by Application (2021-2032)
6 Pronase Regional Sales and Value Analysis
  1. 6.1 Global Pronase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pronase Sales by Region (2021-2032)
  3. 6.2.1 Global Pronase Sales by Region: 2021-2026
  4. 6.2.2 Global Pronase Sales by Region (2027-2032)
  5. 6.3 Global Pronase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pronase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pronase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pronase Sales Value by Region (2027-2032)
  9. 6.5 Global Pronase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pronase Sales Value (2021-2032)
  12. 6.6.2 North America Pronase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pronase Sales Value (2021-2032)
  15. 6.7.2 Europe Pronase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pronase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pronase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pronase Sales Value (2021-2032)
  21. 6.9.2 South America Pronase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pronase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pronase Sales Value Share by Country, 2025 VS 2032
7 Pronase Country-level Sales and Value Analysis
  1. 7.1 Global Pronase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pronase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pronase Sales by Country (2021-2032)
  4. 7.3.1 Global Pronase Sales by Country (2021-2026)
  5. 7.3.2 Global Pronase Sales by Country (2027-2032)
  6. 7.4 Global Pronase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pronase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pronase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pronase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pronase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pronase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pronase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pronase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pronase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pronase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pronase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pronase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pronase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pronase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pronase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pronase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pronase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pronase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pronase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pronase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pronase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pronase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pronase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pronase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pronase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pronase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pronase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pronase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pronase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pronase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pronase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pronase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pronase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pronase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pronase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pronase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pronase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pronase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pronase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pronase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pronase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pronase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pronase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pronase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pronase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pronase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pronase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pronase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pronase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pronase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pronase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pronase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pronase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pronase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pronase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pronase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pronase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pronase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pronase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pronase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pronase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pronase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pronase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pronase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pronase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pronase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pronase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pronase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pronase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pronase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pronase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pronase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pronase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pronase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pronase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pronase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pronase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pronase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pronase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pronase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pronase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pronase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pronase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pronase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pronase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pronase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pronase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP
  2. 8.1.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information
  3. 8.1.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP Business Overview
  4. 8.1.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP Pronase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP Pronase Product Portfolio
  6. 8.1.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Developments
  7. 8.2 Yihe Biotech
  8. 8.2.1 Yihe Biotech Company Information
  9. 8.2.2 Yihe Biotech Business Overview
  10. 8.2.3 Yihe Biotech Pronase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yihe Biotech Pronase Product Portfolio
  12. 8.2.5 Yihe Biotech Recent Developments
  13. 8.3 Beijing Tide Pharmaceutical
  14. 8.3.1 Beijing Tide Pharmaceutical Company Information
  15. 8.3.2 Beijing Tide Pharmaceutical Business Overview
  16. 8.3.3 Beijing Tide Pharmaceutical Pronase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Tide Pharmaceutical Pronase Product Portfolio
  18. 8.3.5 Beijing Tide Pharmaceutical Recent Developments
  19. 8.4 Shanghai Yuanye Bio-Technology
  20. 8.4.1 Shanghai Yuanye Bio-Technology Company Information
  21. 8.4.2 Shanghai Yuanye Bio-Technology Business Overview
  22. 8.4.3 Shanghai Yuanye Bio-Technology Pronase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Yuanye Bio-Technology Pronase Product Portfolio
  24. 8.4.5 Shanghai Yuanye Bio-Technology Recent Developments
  25. 8.5 Shanghai Yiyan Bio-Technology
  26. 8.5.1 Shanghai Yiyan Bio-Technology Company Information
  27. 8.5.2 Shanghai Yiyan Bio-Technology Business Overview
  28. 8.5.3 Shanghai Yiyan Bio-Technology Pronase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Yiyan Bio-Technology Pronase Product Portfolio
  30. 8.5.5 Shanghai Yiyan Bio-Technology Recent Developments
  31. 8.6 QiMing Biotech
  32. 8.6.1 QiMing Biotech Company Information
  33. 8.6.2 QiMing Biotech Business Overview
  34. 8.6.3 QiMing Biotech Pronase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 QiMing Biotech Pronase Product Portfolio
  36. 8.6.5 QiMing Biotech Recent Developments
  37. 8.7 Shanghai Kanglang Biotechnology
  38. 8.7.1 Shanghai Kanglang Biotechnology Company Information
  39. 8.7.2 Shanghai Kanglang Biotechnology Business Overview
  40. 8.7.3 Shanghai Kanglang Biotechnology Pronase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Kanglang Biotechnology Pronase Product Portfolio
  42. 8.7.5 Shanghai Kanglang Biotechnology Recent Developments
  43. 8.8 Shanghai Gelatins
  44. 8.8.1 Shanghai Gelatins Company Information
  45. 8.8.2 Shanghai Gelatins Business Overview
  46. 8.8.3 Shanghai Gelatins Pronase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Gelatins Pronase Product Portfolio
  48. 8.8.5 Shanghai Gelatins Recent Developments
  49. 8.9 Shanghai Acmec Biochemical
  50. 8.9.1 Shanghai Acmec Biochemical Company Information
  51. 8.9.2 Shanghai Acmec Biochemical Business Overview
  52. 8.9.3 Shanghai Acmec Biochemical Pronase Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Acmec Biochemical Pronase Product Portfolio
  54. 8.9.5 Shanghai Acmec Biochemical Recent Developments
  55. 8.10 Roche
  56. 8.10.1 Roche Company Information
  57. 8.10.2 Roche Business Overview
  58. 8.10.3 Roche Pronase Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Roche Pronase Product Portfolio
  60. 8.10.5 Roche Recent Developments
  61. 8.11 Anpel
  62. 8.11.1 Anpel Company Information
  63. 8.11.2 Anpel Business Overview
  64. 8.11.3 Anpel Pronase Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Anpel Pronase Product Portfolio
  66. 8.11.5 Anpel Recent Developments
  67. 8.12 VWR
  68. 8.12.1 VWR Company Information
  69. 8.12.2 VWR Business Overview
  70. 8.12.3 VWR Pronase Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 VWR Pronase Product Portfolio
  72. 8.12.5 VWR Recent Developments
  73. 8.13 Merck Millipore
  74. 8.13.1 Merck Millipore Company Information
  75. 8.13.2 Merck Millipore Business Overview
  76. 8.13.3 Merck Millipore Pronase Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Merck Millipore Pronase Product Portfolio
  78. 8.13.5 Merck Millipore Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pronase Value Chain Analysis
  2. 9.1.1 Pronase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pronase Sales Mode & Process
  6. 9.2 Pronase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pronase Distributors
  9. 9.2.3 Pronase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst